Header Logo

Connection

JOHN VIERLING to Aminoisobutyric Acids

Back to Details
This is a "connection" page, showing publications JOHN VIERLING has written about Aminoisobutyric Acids.
JOHN VIERLING
Connection Strength
0.069
Aminoisobutyric Acids
  1. Glecaprevir-Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection. N Engl J Med. 2018 01 25; 378(4):354-369.
    View in: PubMed
    Score: 0.035
  2. Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection. N Engl J Med. 2017 06 01; 376(22):2134-2146.
    View in: PubMed
    Score: 0.034
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.